Andrea Gramatica, PhD

  • Postdoctoral at Gladstone Institutes
  • Early Career Presenter - Basic Science


My current research focuses on the study of HIV-1 latency reversion in primary CD4 T cells from HIV-infected individuals on ART. Specifically, my work is dedicated to the identification and analysis of novel and non-toxic latency reversing agents (LRA) that are non-toxic, prevent broad T cell activation, but are able to induce LTR transcription and virus pro­duction.